Literature DB >> 26593212

Pharmacokinetic and pharmacodynamic herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide with etoricoxib after oral administration in rats.

Aishwarya Balap1, Bhagyashri Atre2, Sathiyanarayanan Lohidasan3, Arulmozhi Sinnathambi2, Kakasaheb Mahadik4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Andrographis paniculata Nees (Acanthacae) is commonly used medicinal plant in the traditional. Unani and Ayurvedic medicinal systems. It has broad range of pharmacological effects such as hepatoprotective, antioxidant, antivenom, antifertility, inhibition of replication of the HIV virus, antimalarial, antifungal, antibacterial, antidiabetic, suppression of various cancer cells and anti-inflammatory properties. Andrographolide (AN) is one of the active constituent of the A. paniculata Nees extract (APE). They have been found in many traditional herbal formulations in India and proven to be effective as anti-inflammatory drug AIM OF THE STUDY: To evaluate the pharmacokinetic and pharmacodynamic (anti-arthritic) herb-drug interactions of A. paniculata Nees extract (APE) and pure andrographolide (AN) with etoricoxib (ETO) after oral co-administration in wistar rats.
MATERIALS AND METHODS: After oral co-administration of APE (200mg/Kg) and AN (60mg/kg) with ETO (10mg/kg) in rats, drug concentrations in plasma were determined using HPLC method. The main pharmacokinetic parameters of Cmax, tmax, t1/2, MRT, Vd, CL, and AUC were calculated by non-compartment model. Change in paw volume, mechanical nociceptive threshold, mechanical hyperalgesia, histopathology and hematological parameters were evaluated to study antiarthritic activity.
RESULTS: Co-administration of ETO with APE and pure AN decreased systemic exposure level of each compound in vivo. The Cmax, AUC, t1/2 of ETO was decreased whereas Vd and CL of ETO was increased significantly after co-administration of ETO with pure AN and APE. In pharmacodynamic study, ETO alone and ETO+APE (10+200mg/kg) groups exhibited significant synergistic anti-arthritic activity as compared to groups ETO+AN, APE and AN alone.
CONCLUSION: The results obtained from this study suggested that ETO, APE and pure AN existed pharmacokinetic herb-drug interactions in rat which is correlated with anti-arthritic study. Physicians and patients using A. paniculata should have the knowledge about its possible herb-drug interaction with ETO.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Andrographis paniculata extract; Andrographolide; Andrographolide (Pubchem CID: 5318517); Celecoxib (Pubchem CID: 2662); Etoricoxib; Etoricoxib (Pubchem CID: 123619); Herb–drug Interaction; Pharmacodynamics; Pharmacokinetics

Mesh:

Substances:

Year:  2015        PMID: 26593212     DOI: 10.1016/j.jep.2015.11.011

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Andrographolide-loaded silk fibroin nanoparticles.

Authors:  Xu Zhongyu; Ren Jiangmeng; Jing Qiufang; Ren Fuzheng; Huang Mengting; Ding Wenrui; Zeng Bubing
Journal:  RSC Adv       Date:  2018-10-09       Impact factor: 4.036

2.  Investigating the Potential Use of Andrographolide as a Coadjuvant in Sickle Cell Anemia Therapy.

Authors:  Abhishek Gour; Pankul Kotwal; Ashish Dogra; Dilpreet Kour; Sumit Dhiman; Amit Kumar; Sanjeev Kumar Digra; Ajay Kumar; Gurdarshan Singh; Utpal Nandi
Journal:  ACS Omega       Date:  2022-04-04

3.  Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.

Authors:  Le Yang; Chenyang Yan; Feng Zhang; Bo Jiang; Shouhong Gao; Youtian Liang; Lifeng Huang; Wansheng Chen
Journal:  Exp Anim       Date:  2017-11-13

4.  Influence of andrographolide on the pharmacokinetics of warfarin in rats.

Authors:  Xiaoli Zhang; Xiaosu Zhang; Xiaocui Wang; Meijun Zhao
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

Review 5.  A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery.

Authors:  Aekkhaluck Intharuksa; Warunya Arunotayanun; Wipawadee Yooin; Panee Sirisa-Ard
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.